{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:57:04Z","timestamp":1773068224423,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6-7","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.1007\/bf01291883","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T20:13:33Z","timestamp":1111695213000},"page":"649-660","source":"Crossref","is-referenced-by-count":83,"title":["Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's disease"],"prefix":"10.1007","volume":"104","author":[{"given":"J.","family":"Lan","sequence":"first","affiliation":[]},{"given":"D. H.","family":"Jiang","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"CR1","first-page":"749","volume":"227","author":"JD Adams","year":"1983","unstructured":"Adams JD, Lauterberg BH, Mitchell JR (1983) Plasma glutathione and glutathione dissulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther 227: 749?754","journal-title":"J Pharmacol Exp Ther"},{"key":"CR2","first-page":"273","volume-title":"Methods of enzymatic analysis","author":"HE Aebi","year":"1983","unstructured":"Aebi HE (1983) Catalase. In: Burgmeyer HU (ed) Methods of enzymatic analysis, 3rd ed, vol 3. Academic Press, New York, pp 273?286","edition":"3rd ed"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02815368","volume":"20","author":"JS Althaus","year":"1993","unstructured":"Althaus JS, Andrus PK, Williams CM, Von Voigtlander PF, Cazers AR, Hall ED (1993) The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury: reveal by tirilazad mesylate (U74006F). Mol Chem Neuropathol 20: 147?162","journal-title":"Mol Chem Neuropathol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","volume":"32","author":"LM Ambani","year":"1975","unstructured":"Ambani LM, Van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 32: 114?118","journal-title":"Arch Neurol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1471-4159.1991.tb06432.x","volume":"57","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Youdim MBH (1991) Intranigral iron injection induces behavioral and biochemical parkinsonism in rats. J Neurochem 57: 2133?2135","journal-title":"J Neurochem"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0005-2760(87)90072-5","volume":"921","author":"JM Braughler","year":"1987","unstructured":"Braughler JM, Chase RL, Pregenzer JF (1987) Oxidation of ferrous iron during peroxidation of lipid substrates. Biochem Biophys Acta 921: 457?464","journal-title":"Biochem Biophys Acta"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1471-4159.1980.tb07882.x","volume":"35","author":"AJL Cooper","year":"1980","unstructured":"Cooper AJL, Pulsinelli WA, Duffy TE (1980) Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J Neurochem 35: 1242?1245","journal-title":"J Neurochem"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989a) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830?1836","journal-title":"J Neurochem"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.870040209","volume":"4","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Jenner P, Marsden CD (1989b) Oxyferriscorbone elevates the total iron content of blood but not brain. Mov Disord 4: 176?182","journal-title":"Mov Disord"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Cater CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989c) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381?389","journal-title":"J Neurochem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/ana.410320719","volume":"32","author":"DA Monte Di","year":"1992","unstructured":"Di Monte DA, Chan P, Sandy MS (1992) Glutathione in Parkinson's disease: a link between oxidative stress and mitochondria damage? Ann Neurol 32: S111?115","journal-title":"Ann Neurol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-196801000-00001","volume":"27","author":"KM Earle","year":"1968","unstructured":"Earle KM (1968) Studies in Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed tissue. J Neuropathol Exp Neurol 27: 1?14","journal-title":"J Neuropathol Exp Neurol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0076-6879(84)05015-1","volume-title":"Methods in enzymology, vol 105. Oxygen radicals in biological systems","author":"L Flohe","year":"1984","unstructured":"Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. In: Packer L (ed) Methods in enzymology, vol 105. Oxygen radicals in biological systems. Academic Press, New York, pp 114?121"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-022X(84)90042-3","volume":"10","author":"RA Floyd","year":"1984","unstructured":"Floyd RA, Watson JJ, Wong PK (1984) Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Methods 10: 221?235","journal-title":"J Biochem Biophys Methods"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-Q","volume":"208","author":"M Gerlach","year":"1991","unstructured":"Gerlach M, Riederer P, Przuntek H, Youdim MBH (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol (Mol Pharmacol Sect) 208: 273?286","journal-title":"Eur J Pharmacol (Mol Pharmacol Sect)"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1471-4159.1994.63030793.x","volume":"63","author":"M Gerlach","year":"1994","unstructured":"Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative disease? J Neurochem 63: 793?807","journal-title":"J Neurochem"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0197-0186(95)00063-E","volume":"28","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, G\ufffdtz M, Dirr A, Kupsch A, Janetzky B, Oertel W, Sautter J, Schwarz J, Reichmann H, Riederer P (1996) Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin. Neurochem Int 28: 41?49","journal-title":"Neurochem Int"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0163-7258(94)90055-8","volume":"63","author":"ME G\ufffdtz","year":"1994","unstructured":"G\ufffdtz ME, K\ufffdnig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63: 37?122","journal-title":"Pharmacol Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","volume":"3","author":"B Hallgren","year":"1958","unstructured":"Hallgren B, Sourander P (1958) The effect of age on the nonhaemin iron in the human brain. J Neurochem 3: 41?51","journal-title":"J Neurochem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","volume":"59","author":"B Halliwell","year":"1992","unstructured":"Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59: 1609?1623","journal-title":"J Neurochem"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00995149","volume":"20","author":"SJ Heales","year":"1995","unstructured":"Heales SJ, Davies SE, Bates TE, Clark JB (1995) Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 20: 31?38","journal-title":"Neurochem Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"EC Hirsch","year":"1988","unstructured":"Hirsch EC, Graybiel AM, Agid Y (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334: 345?348","journal-title":"Nature"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1471-4159.1992.tb08362.x","volume":"59","author":"K Jellinger","year":"1992","unstructured":"Jellinger K, Kienzl E, Rumperlmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MBH (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 59: 1168?1171","journal-title":"J Neurochem"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0404.1991.tb05013.x","volume":"136","author":"P Jenner","year":"1991","unstructured":"Jenner P (1991) Oxidative stress as a cause of Parkinson's disease. Acta Neurol Scand [Suppl] 136: 6?15","journal-title":"Acta Neurol Scand [Suppl]"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0404.1993.tb00013.x","volume":"146","author":"P Jenner","year":"1993","unstructured":"Jenner P (1993) Altered mitochondria function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol Scand [Suppl] 146: 6?13","journal-title":"Acta Neurol Scand [Suppl]"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0003-9861(88)90509-7","volume":"260","author":"GEN Kass","year":"1988","unstructured":"Kass GEN, Wright JM, Nicoatera P, Orrenius S (1988) The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Arch Biochem Biophys 260: 789?797","journal-title":"Arch Biochem Biophys"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0021-9673(01)94581-9","volume":"386","author":"C Kim","year":"1987","unstructured":"Kim C, Speisky MB, Kharouba SN (1987) Rapid and sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine and their major metabolites in rat brain by high-performance liquid chromatography. J Chromatogr 386: 25?35","journal-title":"J Chromatogr"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3940(85)90078-3","volume":"58","author":"SJ Kish","year":"1985","unstructured":"Kish SJ, Morito C, Hornykiewicz O (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci Lett 58: 343?346","journal-title":"Neurosci Lett"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard PA, Tetrud JW, Irwin I (1983) Chronic parkinsonism in human due to a product of meperidine-analog synthesis. Science 219: 979?980","journal-title":"Science"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265?275","journal-title":"J Biol Chem"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heikilla RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetraphydrophyridine. Life Sci 36: 2503?2508","journal-title":"Life Sci"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"TL Perry","year":"1982","unstructured":"Perry TL, Godin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305?310","journal-title":"Neurosci Lett"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989a) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515?520","journal-title":"J Neurochem"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0404.1989.tb01781.x","volume":"126","author":"P Riederer","year":"1989","unstructured":"Riederer P, Konradi C, Hebenstreit G, Youdim MBH (1989b) Neurochemical perspectives to the function of monoamine oxidase. Acta Neurol Scand 126: 41?45","journal-title":"Acta Neurol Scand"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0361-9230(92)90118-H","volume":"28","author":"GJ Sengstock","year":"1992","unstructured":"Sengstock GJ, Olanow CW, Dunn AJ, Arendash GW (1992) Iron induces degeneration of nigrostriatal neurons. Brain Res Bull 28: 645?649","journal-title":"Brain Res Bull"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jnr.490350109","volume":"35","author":"GJ Sengstock","year":"1993","unstructured":"Sengstock GJ, Olanow CW, Menzies RA, Dunn AJ, Arendash GW (1993) Infustion of iron into the rat substantia nigra: nigral pathology and dose dependent loss of dopaminergic markers. J Neurosci Res 35: 67?82","journal-title":"J Neurosci Res"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/exnr.1994.1187","volume":"130","author":"GJ Sengstock","year":"1994","unstructured":"Sengstock GJ, Olanow CW, Dunn AJ, Barone S Jr, Arendash GW (1994) Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. Exp Neurol 130: 82?94","journal-title":"Exp Neurol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1987.tb03384.x","volume":"49","author":"TP Singer","year":"1987","unstructured":"Singer TP, Castagnoli N Jr, Ramsay RR, Treor AJ (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 49: 1?8","journal-title":"J Neurochem"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","volume":"74","author":"E Sofic","year":"1988","unstructured":"Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MBH (1988) Increase iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74: 199?205","journal-title":"J Neural Transm"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.1991.tb02017.x","volume":"56","author":"E Sofic","year":"1991","unstructured":"Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brain. J Neurochem 56: 978?982","journal-title":"J Neurochem"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","volume":"142","author":"E Sofic","year":"1992","unstructured":"Sofic E, Lange KW, Jellinger K, Riederer P (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett 142: 128?130","journal-title":"Neurosci Lett"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","volume":"86","author":"MB Spina","year":"1989","unstructured":"Spina MB, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Natl Acad Sci USA 86: 1398?1400","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-3806(90)90103-6","volume":"55","author":"E Taylor","year":"1990","unstructured":"Taylor E, Morgan E (1990) Developmental changes in transferrin and iron uptake by the brain in the rat. Dev Brain Res 55: 35?42","journal-title":"Dev Brain Res"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","volume":"27","author":"F Tietze","year":"1969","unstructured":"Tietze F (1969) Enzymic method for quantitative determination of nanogram amount of total and oxidized glutathione. Anal Biochem 27: 502?522","journal-title":"Anal Biochem"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Uchiyama","year":"1978","unstructured":"Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86: 271?278","journal-title":"Anal Biochem"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S0317167100029140","volume":"16","author":"RJ Uitti","year":"1989","unstructured":"Uitti RJ, Rajput AH, Rozdilsky B, Bickis M, Wollin T, Yuen WK (1989) Regional metal concentrations in Parkinson's disease, other chronic neurological disease, and control brains. Can J Neurol Sci 16: 310?314","journal-title":"Can J Neurol Sci"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-5793(91)80200-M","volume":"280","author":"P Werner","year":"1991","unstructured":"Werner P, Cohen G (1991) Intramitochondrial formation of oxidized glutathione during oxidation of benzylamine by monoamine oxidase. FEES Lett 280: 44?46","journal-title":"FEES Lett"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-3940(86)90012-1","volume":"63","author":"VW Young","year":"1986","unstructured":"Young VW, Perry TL, Krisman AA (1986) Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci Lett 63: 56?60","journal-title":"Neurosci Lett"},{"key":"CR49","first-page":"57","volume":"40","author":"MBH Youdim","year":"1993","unstructured":"Youdim MBH, Riederer P (1993) The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J Neural Transm [Suppl] 40: 57?67","journal-title":"J Neural Transm [Suppl]"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00964608","volume":"10","author":"MM Zaleska","year":"1985","unstructured":"Zaleska MM, Floyd RA (1985) Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res 10: 397?410","journal-title":"Neurochem Res"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.1994.62031097.x","volume":"62","author":"L Zecca","year":"1994","unstructured":"Zecca L, Pietra R, Goj C, Mecacci C, Radice D, Sabbioni E (1994) Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J Neurochem 62: 1097?1101","journal-title":"J Neurochem"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-N","volume":"13","author":"MJ Zigmond","year":"1990","unstructured":"Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13: 290?296","journal-title":"Trends Neurosci"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01291883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01291883\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01291883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:27:48Z","timestamp":1683052068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01291883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":52,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["BF01291883"],"URL":"https:\/\/doi.org\/10.1007\/bf01291883","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}